Novartis Venture Fund
Novartis Venture Fund invests in life sciences companies developing biotechnology and biopharmaceutical treatments. It backs businesses at different development stages addressing unmet patient needs and public health challenges.
- Headquarters
- Switzerland
Recorded investments
- Sun King (Greenlight Planet) — Series E · 2020
- mPharma — Series C · 2020